FDA Expands Approval of Osimertinib in Lung Cancer
MedPage Today) -- The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC)...
Anthony Pepper
MedPage Today) -- The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC)...
